Clinical Trial
doi: 10.1016/s1076-6332(03)80415-4.
Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient
Affiliations
- PMID: 12019845
- DOI: 10.1016/s1076-6332(03)80415-4
Item in Clipboard
Clinical Trial
Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient
Acad Radiol.
2002 May.
No abstract available
Similar articles
-
Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay.Clin Imaging. 1998 May-Jun;22(3):180-7. doi: 10.1016/s0899-7071(97)00123-x. Clin Imaging. 1998. PMID: 9559229 Review.
-
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.Radiology. 1996 Jul;200(1):59-67. doi: 10.1148/radiology.200.1.8657946. Radiology. 1996. PMID: 8657946 Clinical Trial.
-
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16. Eur J Radiol. 2013. PMID: 23159401
-
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.Dig Dis. 2015 Oct;33(6):735-44. doi: 10.1159/000439097. Epub 2015 Oct 21. Dig Dis. 2015. PMID: 26488875
-
Primovist, Eovist: what to expect?J Hepatol. 2012 Aug;57(2):421-9. doi: 10.1016/j.jhep.2012.01.031. Epub 2012 Apr 12. J Hepatol. 2012. PMID: 22504332 Review.
Cited by
-
Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.World J Hepatol. 2014 Jul 27;6(7):477-85. doi: 10.4254/wjh.v6.i7.477. World J Hepatol. 2014. PMID: 25067999 Free PMC article. Review.
-
Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis.Hepatol Int. 2013 Jul;7(3):850-8. doi: 10.1007/s12072-012-9419-7. Epub 2013 Jan 30. Hepatol Int. 2013. PMID: 26201922
-
Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations.Yonsei Med J. 2014 May;55(3):651-9. doi: 10.3349/ymj.2014.55.3.651. Epub 2014 Apr 1. Yonsei Med J. 2014. PMID: 24719131 Free PMC article.
-
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.Eur Radiol. 2004 Apr;14(4):559-78. doi: 10.1007/s00330-004-2236-1. Epub 2004 Feb 25. Eur Radiol. 2004. PMID: 14986050 Review.
-
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].Radiologe. 2004 Dec;44(12):1170-84. doi: 10.1007/s00117-004-1142-5. Radiologe. 2004. PMID: 15551031 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical